Skip to content

A Study comparing Subcision followed by Fco2 laser versus Fco2 alone in the treatment of Facial acne scars

Comparative Efficacy of Subcision followed by Fractional Co2 laser versus Fractional Co2 laser monotherapy in the management of Atrophic Acne Scars in a Tertiary Care Centre Chengalpattu A Randomized Controlled Trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112647
Enrollment
50
Registered
2026-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L905- Scar conditions and fibrosis of skin

Interventions

Intervention1: Subcision followed by fractional co2 laser: Participants will undergo one session of subcision followed by three monthly sessions of fractional carbon dioxide laser for the treatment of

Sponsors

DR VISHALI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 years and above with atrophic facial acne scars of Goodman and Baron qualitative grade 2 to 4 who are willing to provide written informed consent and comply with study procedures and follow up visits.

Exclusion criteria

Exclusion criteria: Patients with active inflammatory acne lesions, active herpes infection, tendency for keloid formation, collagen vascular diseases, pregnancy or lactation, history of isotretinoin use within the previous six months.

Design outcomes

Primary

MeasureTime frame
Change in Goodman and Baron quantitative scar grading score Timepoint: Baseline and two months after completion of the third treatment session

Secondary

MeasureTime frame
Change in Observer Scar Assessment Scale score Timepoint: Baseline and two months after completion of the third treatment session ; Change in Patient Scar Assessment Scale score Timepoint: Baseline and two months after completion of the third treatment session ; Patient satisfaction assessed using a five point Likert scale Timepoint: Two months after completion of the third treatment session ; Occurrence of adverse effects including erythema, edema, hyperpigmentation, scaling and persistent erythema Timepoint: Throughout the treatment period and follow up

Countries

India

Contacts

Public ContactN VISHALI

KARPAGA VINAYGA INSTITUTE OF MEDICALL SCIENCE AND RESEARCH CENTRE

sooriakathirvel@gmail.com9500035795

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026